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September 2018 Newsletter  
 
 
 
 
 
CCTS PPP 
LOI deadline: September 14th, 5PM 
Individual project awards (up to $50,000 for 1 year) will be made on a competitive basis. The Principal 
Investigator must be a UMMS Worcester faculty member, but collaborations with faculty on any UMASS 
campus are encouraged. You are welcome to have external or internal collaborators, but this is not a 
requirement.  
For more information visit https://umassmed.edu/ccts/funding/PPP/  
CCTS SPARK Program 
Application Deadline: Rolling Basis 
THE UMCCTS SPARK (Small Pilot and Research Knowledge) Program’s priorities are to support studies that 
impact clinical care and research methodologies, support students and trainees, and provide access to funds 
to generate pilot and preliminary data for external grant submissions. 
For more information: https://www.umassmed.edu/ccts/funding/spark-program/  
CCTS Small Conference Grants 
Application Deadline: Rolling Basis 
THE UMCCTS is pleased to offer Small Conference Grants (SCG). This funding facilitates the development of 
faculty-to-faculty networks within the University system. 
For more information: https://www.umassmed.edu/ccts/funding/small-conference-grants/  
In Good Company: the 2018 Optimal Aging Challenge 
Application Deadline: September 28th 
In Good Company: the 2018 Optimal Aging Challenge, is a global innovation challenge focused on 
identifying breakthrough ideas, products or services to alleviate isolation and loneliness among older adults. 
The Challenge will continue through September 28, and winners chosen in December. 
Visit the challenge website at http://bit.ly/InGoodCompanyChallenge for additional information. 
DRIVe's EZ-BAA application process is now open for business!  
 
Calling all medical product developers, research teams, and companies! Those offering disruptive 
innovative approaches that will transform health security threats are now invited to submit abstracts 
using DRIVe's simplified EZ-BAA process. Applications must offer transformative innovation, 
products, and technologies to protect Americans from health security threats.  
In-scope priority areas include: 
• Products and solutions to reduce illness and death from sepsis as part of DRIVe's Solving Sepsis 
Initiative 
• Technologies and processes to identify infections and exposures to biological and other health 
threats, as outlined in the Early Notification to Act, Control, and Treat (ENACT) initiative 
• Tools and techniques to mitigate the damages and loss of life associated with catastrophic events 
Download the application and learn about next steps here. 
Learn more about the DRIVe EZ-BAA review criteria.  
Have questions or looking for more information? Contact DRIVeContracting@hhs.gov  
 
Collaborative Funding Opportunities 
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CLIC is pleased to announce two funding opportunities for collaborative efforts to help advance translational 
and team science throughout the consortium. Teams are invited to apply for support to write a Synergy Paper 
or host an Un-Meeting. More information and all application requirements can be found on CLIC’s website: 
Un-Meeting Request for Applications  
Synergy Paper Request for Applications  
NCATS Funding Available to Repurpose Existing Drugs 
NCATS has announced funding opportunities to use partially developed therapeutic candidates to identify new 
treatments for a broad range of diseases. 
Full details here: https://ncats.nih.gov/news/releases/2018/ntu-foa-2018  
 
 
 
 
 
 
I-Corps Program  
APPLY NOW! Application Deadline September 17, 2018. 
Does your latest discovery have commercial value? Would a potential "customer" of your research welcome your 
technology, protocol, or intervention? 
The I-Corps Program at the UMCCTS is designed to support the translation of biomedical research by providing 
early-stage education and strategic guidance to faculty, staff and students during the ideation phase of 
technology development. 
Course starts on October 23, 2018. For more information: https://umassmed.edu/ccts/education/i-corps-
program-at-the-umccts/  
Questions? Contact Nate Hafer at Nathaniel.hafer@umassmed.edu  
Learn more about a similar course that was recently held at UAB: https://youtu.be/xXZoWy0-x2g 
K Club 
The CCTS Research Career & Writing Group (K-Club) meets every first and third Wednesday to provide 
information and feedback on Research Career Award applications (NIH K Awards, VA Research Career 
Awards, CTSA K grants, etc.). Participants receive feedback on their biosketch, training plans, research plan, 
specific aims, and a wealth of other information.  
Where: 1st and 3rd Wednesday of the month from 4:00pm - 5:00pm in ASC5-2072 
More information: https://www.umassmed.edu/ccts/education/k-club  
Projects in Progress Seminar Series (PiPSS) 
PiPSS is designed to give CCTS trainees and junior faculty an opportunity to present their work in a structured 
format and in a forum of peers and faculty with the goal of ensuring continuous, professional feedback and 
cross-fertilization that is required for excellence in research. The first session of the 2018-19 academic year will 
be on Thursday, October 18th at 3:30PM in Room ASC8-2072 (Albert Sherman Building). 
Speakers for the October 18th session are (all titles TBA): 
• Ana-Luisa Maldonado-Contreras 
• Teresita Padilla-Benavides 
• Maggi Ahmed 
• James Strassner 
New Clinicaltrials.gov Education sessions have been added! 
Are you a PI or study team member for a human research study? Clinicaltrials.gov registration isn’t limited to 
drug or device trials: it can include any human research study which prospectively assigns participants to one 
or more intervention to evaluate the effects on health outcomes. It can include surgical and behavioral 
interventions as well as drug and device studies. Failure to properly register a trial can lead to denial of study 
publication, restriction in funding and civil monetary penalties. 
Join Meg Johnson (meg.johnson@umassmed.edu), HRPP Compliance Administrator and UMMS 
Clinicaltrials.gov point of contact to learn more about registration, maintenance and result reporting 
requirements for clinicaltrials.gov.  
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 Research Study Design and Analysis Series 
Session I: Design, Conduct, and Analysis of Observational Studies 
In this first session, attendees will learn about the design, conduct, and analysis of case-control (retrospective) 
and longitudinal (prospective) studies that are commonly utilized in clinical and public health research. This two 
hour session will cover various topics that pertain to these non-randomized observational studies including 
when to use which observational design approach, development of study hypotheses, comparison groups to 
be studied, sample size/power calculations, data collection activities, and data analysis and interpretation.  
Date: October 9, 2018 
Time: 3:00 – 5:00 PM 
Location: Albert Sherman Building, 6th Floor, AS6-2072 
Session II: Design, Conduct, and Analysis of Randomized Controlled Trials 
In this second session, attendees will learn about the design, conduct, and analysis of randomized controlled 
clinical trials (RCTs). This two hour session will cover various topics that pertain to RCTs including the 
development of study hypotheses, trial design (including sample size/power estimation), patient recruitment 
and enrollment, reasons for randomization and common randomization approaches, data collection activities, 
data analysis (including interim and final analyses), and presentation. 
Date: October 16, 2018 
Time: 3:00 – 5:00 PM 
Topic Date Time Prerequisite Registration Link  
Clinicaltrials.gov 
Basics: 
Registration 
  
9/13/18 10:00 
AM – 
11:00 
AM 
N 
https://i.umassmed.edu/inside/display/EventDisplay.aspx?sID=18367  
 
9/25/18 3:00 
PM –  
4:00 
PM 
N 
https://i.umassmed.edu/inside/display/EventDisplay.aspx?sID=18368  
 
Clinicaltrials.gov 
Basics: Record 
Maintenance 
and Results 
Reporting 
  
  
9/14/18 10:00 
AM - 
11:00 
AM 
Y 
https://i.umassmed.edu/inside/display/EventDisplay.aspx?sID=18369  
 
Clinicaltrials.gov 
Intermediate: 
Registration 
  
9/12/18 10:00 
AM - 
11:00 
AM 
Y 
https://i.umassmed.edu/inside/display/EventDisplay.aspx?sID=18372  
 
9/26/18 10:00 
AM - 
11:00 
AM 
Y 
https://i.umassmed.edu/inside/display/EventDisplay.aspx?sID=18373  
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Location: Albert Sherman Building, 6th Floor, AS6-2072 
 
 
 
 
 
 
UMMS-Baystate Celebration of Research and Academic Innovation 
Please join us for our annual daylong Celebration of Research and Academic Innovation on September 12th, 
2018. This year our Keynote Speaker will be Dr. David Asch, MD, MBA, Executive Director of the Penn 
Medicine Center for Health Care Innovation & Professor of Health Care Management, the Wharton School. He 
will present Behavioral Economics: Understanding how patients & physicians make medical choices in clinical, 
financial, and ethically charged settings” at Grand Rounds (8:00 am in Chestnut 1A/B) and also give a noon-
time lecture (Chestnut 5).  
In addition for an opportunity to “Meet the Professor” (Dr. Asch), there will be symposia and workshops on a 
variety of topics throughout the day with the goal of promoting research among Baystate faculty and staff. 
From 9:00am to 6:00 pm posters will be available for viewing in the Health Sciences Library, Chestnut 
Conference Center.  
Questions? Contact Susan Decelle, Susan.Decelle@baystatehealth.org 
Webinar: REDCap - New Modules Supporting eConsent + EHR workflow and data interoperability 
This webinar will provide an overview of new features in REDCap to support electronic consent using 
REDCap's new e-Consent Framework module, which allows users to add an e-Consent confirmation screen to 
their surveys while also providing automatic backup of the PDF e-Consent file. Also included is an overview of 
the ability to seamlessly import clinical data from Epic into REDCap using the new REDCap "DDP on FHIR" 
functionality. 
When: Wed, Sep 19, 2018 12:00 PM - 1:00 PM EDT 
To register: https://register.gotowebinar.com/register/8727300270785786625  
Bioinformatics Core Seminar Series 
DolphinNext: A graphical user interface for distributed data processing of high throughput genomics 
DolphinNext is a highly parallel platform specifically designed to process high volumes of data. DolphinNext 
allows users with little bioinformatics knowledge to process their own data on an HPC systems, Amazon Cloud 
or any workstation using a user-friendly web interface.  
When: Thursday, September 27th, 10AM 
Where: UMMS, Albert Sherman Center, 6th floor conference Room 2072 
NCATS Day 2018 
Registration is now open for NCATS Day 2018: Engaging Patients and Communities for Smarter Science on 
Sept. 28, 2018 from 8:30-5 on the NIH main campus in Bethesda, Maryland. 
The purpose of the event is to provide a forum to share and reflect upon patient and community needs — as 
well as best practices in addressing those needs — so that NCATS can best shape its research priorities, 
programs and initiatives. 
Patients and patient advocates, caregivers, community partners, community health engagement professionals, 
clinical and translational researchers, and others are urged to attend to share and discuss ways to overcome 
translational research challenges and leverage opportunities through effective patient and community 
engagement. Participants will learn strategies to broaden participation in research and to incorporate diverse 
patient and community input into their work. 
 
Admission is complimentary, but space is limited, so be sure to register early.  
View the tentative agenda 
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Learn more about the event 
Register now 
Warren Alpert Foundation Prize Symposium 
honoring 
Francis Collins, Paul Negulescu, Bonnie Ramsey, Lap-Chee Tsui, Michael Welsh 
for pioneering contributions to the discovery of the cystic fibrosis transmembrane conductance regulator 
(CFTR) gene and to the subsequent research that led to the development of transformational precision 
medicines to treat the underlying cause of cystic fibrosis. 
Cystic Fibrosis: From Gene Discovery to Basic Biology to Precision Medicines 
When: Thursday, October 4, 2018, 1:30 – 5:30 p.m. 
Where: Joseph B. Martin Conference Center, New Research Building, Harvard Medical School, 77 Avenue 
Louis Pasteur, Boston 
RSVP: wap@hms.harvard.edu 
For complete information visit: http://warrenalpert.org/symposium 
QHS Special Seminar 
Title: Explaining Disparities: Bringing Together Approaches from Epidemiology and Economics Under a Causal 
Framework 
Presented by: John Jackson, ScD; Assistant Professor, Departments of Epidemiology and Mental 
Health, Johns Hopkins Bloomberg School of Public Health 
When: Thursday, October 11, 2018, 12:00 – 1:00 PM 
Where: Albert Sherman Building, AS9-2072 
M2D2'S BARRACUDA BOWL 
October 23rd, 2018 | 5:00 pm - 9:00 pm 
Mintz Levin, 1 Financial Center, Boston MA 
 
Like "Shark Tank"—but instead of business pitches, M2D2 affiliate entrepreneurs will face off to present 
their medtech plans to a panel of judges. Will they thrive under the pressure or drown among the 
barracudas? 
Enjoy the show, network, and have some fun with us this October in Boston! 
 
 
 
 
 
 
Recruitment and Retention Toolkit 
The Trial Innovation Network accepts toolkit submissions from CTSAs and reputable community health partners and 
provides them as a free resource to the research community. The materials on this site are designed primarily for 
CTSA Program staffs. These resources are intended to provide a variety of information that includes best practices 
and evidence-based recruitment and retention strategies. 
Full information here: https://trialinnovationnetwork.org/recruitment-retention-toolkit/?key-element=1681  
CTSA Program hubs collaborate to help researchers navigate regulatory environment 
Three North Carolina Clinical and Translational Science Awards (CTSA) Program hubs have collaborated to 
create a platform for sharing regulatory expertise and best practices. The Regulatory Guidance for Academic 
Research of Drugs and Devices (ReGARDD) Program provides researchers with regulatory guidance, 
education, and consultative support, to ultimately help them move promising products and novel discoveries to 
clinical trials. 
ReGARDD, which is coordinated by the hubs at Duke University, the Wake Forest School of Medicine, and the 
University of North Carolina at Chapel Hill (UNC-Chapel Hill) with partner RTI International, officially launched 
in 2015 and has been developing since. The program builds upon the existing services and knowledge of the 
North Carolina CTSA Program Regulatory Groups and the Research Triangle Park (RTP). 
READ THE FULL STORY.  
Visit the ReGARDD Program website. 
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National Center for Data to Health (CD2H) 
The goal of CD2H is to make data more meaningful, open, and accessible. The CD2H supports a vibrant and 
evolving collaborative informatics ecosystem for the CTSA Program and beyond. The CD2H harnesses and 
expands an ecosystem for translational scientists to discover and share their software, data, and other 
research resources within the CTSA Program network. The CD2H also creates a social coding environment for 
translational science institutions, leveraging the community-driven DREAM challenges as a mechanism to 
stimulate innovation. 
The CD2H homepage is here: https://ctsa.ncats.nih.gov/cd2h/  
To sign up for their mailing list visit: https://nih.us18.list-
manage.com/subscribe?u=71a7d6465fe8d21880b224d23&id=73804c2f34  
 
 
 
 
 
 
 
Have you had research published that cites the UMass Center for Clinical and Translational Science? Has a 
patent been filed on technology developed using Center funding or resources? Did your pilot project receive 
external grant funding? Share it with us at ccts@umassmed.edu . Sharing your successes helps show the 
importance and the effect of the Center for Clinical and Translational Science at UMass. 
 
---  
You are currently subscribed to umccts as: nathaniel.hafer@umassmed.edu.  
To unsubscribe click here: http://list.umassmed.edu/u?id1393F&n=l=ccts&o 40194  
or send a blank email to leave-2040194-191393F@list.umassmed.edu  
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